NASDAQ:CRVO | Free Cash Flow | CervoMed Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.02M
2025-12-31-$6.58M
2025-03-31-$3.89M
2024-12-31-$8.05M
2024-03-31-$1.42M
2023-12-31-$2.54M
2023-03-31-$1.48M
2022-12-31-$692,530.00
2022-03-31-$4.73M
2021-12-31-$3.03M
2021-03-31-$5.18M
2020-12-31-$3.39M
2020-03-31-$3.5M
2019-12-31-$2.44M
2019-03-31-$2.66M
2018-12-31-$3.03M
2018-03-31-$3.29M
2017-12-31-$2.28M$9,219.00-$2.29M-128.04%
2017-03-31-$3.42M$6,372.00-$3.42M
2016-12-31-$1.41M$0.00-$1.41M
2016-03-31-$4.63M$1,994.00-$4.63M
2015-12-31-$2.27M$26,647.00-$2.29M
2015-03-31-$938,778.00$2,183.00-$940,961.00
2014-12-31-$1.93M
2014-03-31-$432,893.00
2013-12-31-$633.00
2013-03-31-$306,183.00
2011-12-31-$3.22M
2010-12-31-$390,993.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$23.45M
2024-12-31-$16.53M
2023-12-31-$7.45M
2022-12-31-$2.57M
2021-12-31-$14.5M
2020-12-31-$13.55M
2019-12-31-$9.86M
2018-12-31-$10.77M
2017-12-31-$12.33M$447,823.00-$12.78M
2016-12-31-$10.77M$2,331.00-$10.77M
2015-12-31-$5.19M$40,291.00-$5.23M
2014-12-31-$9.03M$50,911.00-$9.08M
2013-12-31-$1.18M
2011-12-31-$12.02M
2010-12-31-$1.98M